Cargando…
Development and management of systemic lupus erythematosus in an HIV-infected man with hepatitis C and B co-infection following interferon therapy: a case report
INTRODUCTION: The association of human immunodeficiency virus and immune dysfunction leading to development of autoimmune markers is well described, but human immunodeficiency virus infection is relatively protective for the development of systemic lupus erythematosus. In contrast, development of sy...
Autores principales: | Abbott, Iain J, Chang, Christina C, Skinner, Matthew J, Street, Alison, Perry, Greg, McLean, Catriona, Wright, Edwina J, Cameron, Paul U |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2726516/ https://www.ncbi.nlm.nih.gov/pubmed/19830165 http://dx.doi.org/10.4076/1752-1947-3-7289 |
Ejemplares similares
-
Interferon Alpha in Systemic Lupus Erythematosus
por: Niewold, Timothy B., et al.
Publicado: (2010) -
Interferon targeted therapies in systemic lupus erythematosus
por: Misra, Durga Prasanna, et al.
Publicado: (2017) -
Infections and systemic lupus erythematosus
por: Skare, Thelma Larocca, et al.
Publicado: (2016) -
Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
por: Bennett, Lynda, et al.
Publicado: (2003) -
Systemic lupus erythematosus and the type I interferon system
por: Rönnblom, Lars, et al.
Publicado: (2003)